| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2022 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $259.05 | $1,554,295.69 | -3.8% | -4.3% | -13.5% | |
| Nov 17, 2022 | LNTH Lantheus Holdings, Inc. | Blanchfield Paul54 | Chief Operating Officer | Sell | 2,432 | $54.79 | $133,249.28 | -3.2% | +8.9% | +23.8% | |
| Nov 17, 2022 | UTHR United Therapeutics Corp | Patusky Christopher50 | Director | Sell | 100 | $262.61 | $26,261.00 | -8.3% | -4.3% | -13.5% | |
| Nov 17, 2022 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $261.52 | $4,184,294.76 | -31.0% | -4.3% | -13.5% | |
| Nov 16, 2022 | CRON Cronos Group Inc. | Adler Jason Marc49 | Director | Buy | 280,860 | $3.04 | $855,137.42 | +55.1% | -22.0% | -36.6% | |
| Nov 15, 2022 | LNTH Lantheus Holdings, Inc. | Sabens Andrea47 | Chief Accounting Officer | Sell | 386 | $59.00 | $22,774.00 | -0.6% | -1.5% | +15.8% | |
| Nov 15, 2022 | INIS International Isotopes Inc | Grosso Christopher G | Director | Buy | 1,410,000 | $0.03 | $42,300.00 | +14.8% | - | - | |
| Nov 15, 2022 | LNTH Lantheus Holdings, Inc. | Marshall Robert J. Jr.53 | CFO And Treasurer | Sell | 5,000 | $59.00 | $295,000.00 | -4.0% | -1.5% | +15.8% | |
| Nov 15, 2022 | SUPN Supernus Pharmaceuticals, Inc. | Khattar Jack A.64 | President, CEO | Sell | 1,115 | $35.00 | $39,028.01 | -0.1% | +16.0% | -15.9% | |
| Nov 15, 2022 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $258.21 | $4,131,330.12 | -28.7% | -1.2% | -11.5% | |
| Nov 15, 2022 | TKNO Alpha Teknova, Inc. | Hood Lisa54 | Chief People Officer | Sell | 2,046 | $5.28 | $10,811.27 | -6.1% | +10.8% | -60.1% | |
| Nov 14, 2022 | ALKS Alkermes Plc. | Daglio David Angelo Jr. | Director | Buy | 35,000 | $23.31 | $815,734.50 | +77.8% | +21.5% | +6.1% | |
| Nov 14, 2022 | BCRX Biocryst Pharmaceuticals Inc | Babu Yarlagadda S66 | Chief Discovery Officer | Sell | 31,515 | $13.88 | $437,428.20 | -9.5% | -25.1% | -61.2% | |
| Nov 14, 2022 | TKNO Alpha Teknova, Inc. | Gelhaus Ken47 | Chief Commercial Officer | Buy | 1,422 | $4.23 | $6,019.33 | New | +19.3% | -58.0% | |
| Nov 14, 2022 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 22,000 | $5.98 | $131,600.00 | -3.4% | +58.5% | +22.1% | |
| Nov 14, 2022 | TKNO Alpha Teknova, Inc. | Hood Lisa54 | Chief People Officer | Buy | 2,818 | $6.07 | $17,099.45 | +4.6% | +19.3% | -58.0% | |
| Nov 14, 2022 | TKNO Alpha Teknova, Inc. | Gunstream Stephen47 | President And CEO | Buy | 3,008 | $7.11 | $21,386.68 | +5.1% | +19.3% | -58.0% | |
| Nov 11, 2022 | ELAN Elanco Animal Health Inc | Bilbrey John P49 | Director | Buy | 7,500 | $13.24 | $99,267.00 | +21.9% | -2.3% | -20.9% | |
| Nov 11, 2022 | SUPN Supernus Pharmaceuticals, Inc. | Bhatt Padmanabh P.69 | Sr. VP Of Ip, CSO | Sell | 6,800 | $34.95 | $237,655.24 | -80.5% | +11.3% | -23.9% | |
| Nov 11, 2022 | LNTH Lantheus Holdings, Inc. | Niedzwiecki Daniel54 | See Remarks | Sell | 3,000 | $59.73 | $179,190.00 | -4.4% | +4.2% | +12.4% | |
| Nov 11, 2022 | BTAI Bioxcel Therapeutics, Inc. | Nandabalan Krishnan75 | Director, 10% Owner | Sell | 60,000 | $15.00 | $900,000.00 | -100% | +104.4% | -67.3% | |
| Nov 11, 2022 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $258.55 | $4,136,827.32 | -22.3% | -0.9% | -12.8% | |
| Nov 10, 2022 | MRK Merck & Co., Inc. | Mizell Steven52 | EVP, Chief Hr Officer | Sell | 35,000 | $101.18 | $3,541,277.50 | -35.3% | +5.4% | +2.2% | |
| Nov 10, 2022 | NBIX Neurocrine Biosciences Inc | Benevich Eric62 | Chief Commercial Officer | Sell | 24,693 | $125.33 | $3,094,855.59 | -44.1% | -15.2% | -13.0% | |
| Nov 9, 2022 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 8,000 | $264.45 | $2,115,602.12 | -28.8% | -3.3% | -16.1% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.